Esther Pogatzki-Zahn (EPZ) is an MD since 1996, did neuroscience training in the US (1998-2003) and is currently a Professor in the Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster/ WWU, Germany, where she works as a pain specialist (head of pain service) and PI of the "Translational Pain Research Group". Her research is aiming to provide insight into the neuropathology of postsurgical, pelvic, chronic inflammatory, neuropathic and cancer-related pain by using basic science in-vivo behavioral, electrophysiological, omics, optogenetic, fMRI and molecular methods as well as human translational pain studies. Furthermore, she performs clinical pain-related studies encompassing a bio-psycho-social spectrum related to the pain entities mentioned above and is involved as a PI or Co-PI in many international multicenter projects, for example IMI-PainCare (imi-paincare.eu), PANDOS (esaic.org/pandos), POET-Pain (poet-pain.de), IT-Pain (itpain.org), ENTRUST-PE (entrust-pe.org) and IN-CHILDPAIN (in-childpain.org). She performs systematic reviews and meta-analysis related to pain, regional anesthesia and perioperative medicine (pre-clinical and clinical) including methods to improve their methodology/design. Her recent work encompasses as well the field of Core Outcome Sets in pain and anesthesia, for example within INTEGRATE and IMI-PainCare, among others. Currently, her research is supported by grants from the German Research Foundation (DFG), the Federal Ministry of Education and Research (BMBF), the Federal Joint Committee (G-BA) and the Innovative Medicines Initiative 2 (IMI). She is council member of the International Association for the Study of Pain (IASP), board member of the German Pain Society, board member of the Acute Pain SIG of the IASP, past chair of the subcommittee "Acute and Chronic Pain and Palliative Medicine Pain Management" of ESAIC, member of the research committee of the ESAIC and member of the European Society of Regional Anaesthesia & Pain Therapy (ESRA) PROSPECT group (esraeurope.org/pain-management) and chair of the European Pain Federation (EFIC) Research Group and member of the Pain, Palliative and Supportive (PAPAS) Cochrane Group (papas.cochrane.org). She is Deputy Editor in Chief for the EJA and EJAIC, section editor for the EJP and reviewer for many international peer review journals. She published more than 150 original peer reviewed manuscripts, 50 review articles/ editorials, 16 Book chapters and 3 books (h-Index: 53).
Biosketch: Lars Arendt-Nielsen Professor, dr med, ph d, head of research, Aalborg University and Aalborg University Hospital, Aalborg Denmark.
Ph D (1987), Clinical Neurophysiology, Aalborg University, Denmark. Dr Med (1994), Medical Faculty, Aarhus University, Denmark. Professor in Clinical and Experimental Pain Research, Aalborg University, Denmark (1993-). Co-founder and principal investigator, Center for Sensory-Motor Interaction - SMI, Aalborg University, Denmark (1993-). Co-founder and principal investigator, Center for Neuroplasticity and Pain (CNAP), Aalborg University, Denmark (2017-). Current guest professor: Dipartimento di Medicina e Chirurgia, Università degli Studi di Parma, Parma, Italy; Department of Anesthesia and Pain Management, University of Seattle, USA.
His interdisciplinary, internationally recognized translational and clinical pain research unit has been developed over the last 40 years with scientists coming from all over the world. The research focuses are: 1) translational pain research; 2) human biomarkers for the clinical assessment of pain; 3) development of human diagnostic pain biomarkers for screening of new analgesic procedures/compounds; 4) proof-of-concept and target validation studies of patients related outcomes in relation to mechanistic pain biomarkers. He is founder of a large research group in the field of interdisciplinary translational experimental and clinical pain research and founder of the clinical trial unit C4Pain which is involved in profiling and screening of new analgesic compounds utilizing advanced human pain biomarkers and patient related outcomes.
He has published 1,346 peer reviewed journal papers (sum of times cited 49,803, average citations per item 37.71, H-index 106, Web of Science) within pain neurobiology, clinical and experimental pain assessment, pain management, musculoskeletal and visceral pain, long-COVID, neuropathy, bio-markers, itch, and profiling of analgesics. Edited six books and been guest editor for two international journals. Full CV: vbn.aau.dk/persons/110350.
Has supervised and completed more than 50 Ph.D. students. Been guest professor in Japan, Sweden, Italy, Switzerland, and USA. Has served on the council of the International Association for the Study of Pain (IASP), president of the IASP Global Year Against Musculoskeletal Pain 2010, president of the IASP Global Year Against Joint Pain 2016, co-founder of IASP’s Special Interest Group (SIG) on Musculoskeletal Pain, head of the IASP Grant Committee, Editor-in-Chief of IASP Press, Served as President-Elect of IASP, president and immediate past-president from 2018-2022. Received more than 20 national and international honors and awards.
Geert Crombez is Professor of Health Psychology at Ghent University (Belgium). Since 1998 he (co-)chairs the Ghent Health Psychology Lab (GHPLAB, https://www.ghplab.ugent.be), which consists of 5 academic staff, 5 postdoctoral researchers and 11 PhD students. Geert Crombez stimulates critical thinking on (1) concepts, (2) the (mis)use of theoretical concepts (somatization, acceptance, catastrophizing), (3) their appropriate measurement via self-report (questionnaires, patient reported outcomes), (4) causality, and (5) the practice/philosophy of science. He has created a research environment with high-level topical expertise embedded within a meta-perspective on the foundations and practice of science. Along with his students, he is strongly involved in providing critical and systematic reviews of the field, which often resulted in key papers. Geert Crombez is currently (co-)author of over 425 publications. He has published in the most important journals in his field, amongst which four papers in Psychological Bulletin, and a paper in The Lancet Child & Adolescent Health Commission on paediatric pain. He is (co)author of four highly cited papers in the Web of Science, and author of two edited books published by Oxford University Press. He was the section editor of Health Psychology of a 10-volume book on clinical psychology (2nd edition of Comprehensive Clinical Psychology). Since 2023 he is editor in chief of Health Psychology Review
Conflict of interest
Geert Crombez has been awarded research grants of the Research Foundation Flanders (FWO) and Ghent University for research on the psychological aspects related to pain, distress and disablity, and for research on the promotion of physical activity in diverse populations. He is currently involved in the UK Advanced Pain Discovery Platform (APDP) PAINSTORM (as co-PI), in the APDP Consortium to Research Individual, Interpersonal & Social Influences in Pain (CRISSP, as member of advisory board), and in the APDP projects CHIPP and Forecast (as affiliated reseacher). He receives consultancy for advising a company MoveUP in developing a digital intervention to promote a healthy lifestyle in bariatric patients. Geert Crombez is currently editor in chief of Health Psychology Review. He is also member of the steering committee of the Behavioural and Social Sciences Ontology (BSSO) Foundry. He is also member of the international advisory board of GALENOS (Global Alliance for Living Evidence on aNxiety, depressiOn and pSychosis), which aims to develop an ontology in the domain of mental health.
Luda Diatchenko, MD, PhD is a Canada Research Chair in Human Pain Genetics and a Professor at the Faculty of Dentistry and Medicine, at McGill University. Dr. Diatchenko earned her MD and PhD in the field of Molecular Biology from the Russian State Medical University. Dr. Diatchenko started her career in industry, she was a Leader of the RNA Expression Group at Clontech, Inc., and subsequently, Director of Gene Discovery at Attagene, Inc. During this time, Dr. Diatchenko was actively involved in the development of several widely-used and widely-cited molecular tools for the analysis of gene expression and regulation. Dr. Diatchenko’s academic career started in 2000 in the Center for Neurosensory Disorders at the University of North Carolina. Her research since then is focused on determining the genetic mechanisms that impact and shape human pain perception and risk of development of chronic pain conditions, enabling new approaches to identify drug targets, treatment responses to analgesics, and diagnostics. In total, Dr. Diatchenko has authored or co-authored over 150 peer-reviewed research papers in journals, 10 book chapters, and edited a book in human pain genetics. She is a past and current member and an active officer of several national and international scientific societies, including the International Association for the Study of Pain, the American Pain Society, and Canadian Pain Society.
Conflict of interest
Dr. Diatchenko’s program aims to identify a mosaic of “pain genes” and biological pathways contributing to human chronic pain via genome-wide approaches, understand pathophysiology of chronic pain, and find new pain drug targets. Dr. Diatchenko’s program will allow prediction of new drug efficacy for multiple chronic pain conditions based on individual genetic profiles. It is the world’s substantial, multidisciplinary effort based on human molecular genetic profiles with potential to transform pain management.
Brona Fullen is an Associate Professor in the UCD School of Public Health, Physiotherapy and Sports Science, Dublin, Ireland. She holds a BSc Physiotherapy (UUJ) and PhD (UCD) degrees. Clinically Brona specialised in the topic of pain working in Pain services at Massachusetts General Hospital, Boston, St Vincent’s University Hospital and Tallaght Hospital Dublin. In UCD she teaches in the area of pain science to both undergraduate and postgraduate students. She is a founder and co-Director of the UCD Centre for Translational Pain Research. Her research areas of interest include pain science education, health literacy and the rehabilitation of people with chronic pain in a range of conditions including musculoskeletal dysfunction, obesity, and spinal cord injury. She has supervised MSc and PhD students to completion in these areas and presented at national and international meetings. Brona is a past President of the Irish Pain Society and is currently Immediate President of the European Pain Federation EFIC, the first female and physiotherapist to hold this post. In 2023 World Physiotherapy presented Brona with an international award for her contribution to the profession.
Conflict of interest
The use of technology (2D and 3D) for the multidisciplinary assessment and management of people living with pain
The use of technology (2D and 3D) ) for pain science education and clinical reasoning for physiotherapy students
LAVAND’HOMME Patricia Marie, MD, PhD. Patricia Lavand’homme, Professor of Anesthesiology, is currently working in St Luc Hospital, Université Catholique de Louvain, Brussels, Belgium. She is the director of the Acute Postoperative Pain Service and the Transitional Pain Service. Her clinical work is dedicated to Orthopedic Anesthesia, Obstetric Anesthesia and Pain Clinic. Her main topics of interest are the management and the pathophysiological mechanisms of acute postoperative pain and chronic post-surgical pain. She has contributed to develop ERAS programmes in abdominal and orthopedic surgery. She has a PhD degree in Medical Science. Patricia did a visiting Scholarship Program at the Wake Forest University School of Medicine, Winston Salem, North Carolina, USA (Pain Mechanisms Laboratory, Pr Eisenach). She also has served as Chairperson of the Scientific Subcommittee “Acute and Chronic Pain” in the European Society of Anaesthesiologists (ESA). She is a member of the international PROSPECT working group and participated in the IASP Task Force working with WHO on Pain Classification for ICD-11 (working on chronic postsurgical and posttraumatic pain). She is an Associated Member of the Royal Academy of Medicine of Belgium and participates in several international consortia dedicated to perioperative pain management (IMI-Pain Care, PROMPT, QS Pain Relief, ICAROS, Hip ATTACK-2). She has served as an associate editor and reviewer for various scientific journals and has published more than 120 articles (h-Index 52).
Conflict of interest
Nothing to declare.
Jordi Miró obtained his PhD (1993) in Health Psychology at Universitat Autònoma de Barcelona. Following postdoctoral training at the University of Pittsburgh, University of Washington, and New York University (1994-1995), he returned to Spain and joined the faculty in the Department of Psychology at the Universitat Autònoma de Barcelona (1996), the Universitat de les Illes Balears (1997-1998) and the Universitat Rovira i Virgili (URV; 1999-) where he was promoted to full professor in 2009 and has served as director of the Master program in Health Psychology since 2000. In 2012 he received the URV's RQR Award for quality in research, and an ICREA-Acadèmia excellence in research award in 2014 and 2020 from the Catalan government, for his studies in pediatric pain. He is founder and director of the Unit for the Study and treatment of Pain – ALGOS (2000-) and of the Chair in Pediatric Pain (2015-) at URV. He has been the principal or co-investigator of over 20 research projects funded by the Spanish Ministry of Science and the Catalan Government, focusing on the epidemiology of chronic pain in childhood, factors involved in development and maintenance of chronic pain in children, and the assessment and treatment of chronic pain, including the use of new technologies (particularly mobile applications). He has published over 190 articles in peer-reviewed journals, written 15 chapters and authored/edited 4 books (h-Index: 43; i10-index: 117).
Dr. Petersen received his Master of Science degree (in 2011) and later a Ph.D. degree in neuroscience (in 2014). In 2021, he received his higher doctorate degree within medicine based on his work on profiling patients with osteoarthritis and linking these profiles to clinical treatment outcomes. Specifically, Dr. Petersen has published studies on how quantitative sensory testing (QST), inflammatory, and psychological findings can be linked with treatment outcomes. The long-term mission for Dr. Petersen is to develop the concept 'Personalized Mechanistic Pain Medicine' to provide the correct treatment to the right patient in a fast, evidence-based, and safe manner. Specifically, Dr. Petersen study factors that modulates pain mechanisms and aim to target these mechanisms using tailored interventions to provide pain relief for patients with chronic pain. Dr. Petersen has published more than 100 scientific peer-reviewed manuscripts. Additionally, Dr. Petersen serves the International Association for the Study of Pain (IASP) as a member of the Fellowships, Grants, and Awards Working Group and he is the chair for the Musculoskeletal Special Interest Group under IASP (in the years 2022-2024).
Bruno Pradier (BP) graduated at the University of Bonn where he received extensive training in behavioral biology and animal pain models. Following his PhD, he took on a postdoctoral stay in the in the laboratory of Julie Kauer at Brown University from 2015-2019. Here, he successfully worked on synaptic and neuronal plasticity and developed novel in vitro models related to craniofacial pain, including headache and migraine. For his work he was recognized with an award by the American Headache Society (2017). In 2019 he joined the laboratories of Esther Pogatzki-Zahn (EPZ) and Cornelius Faber (CF) at the University of Münster to investigate behavioral and cerebral plasticity in animal models for post-surgical and neuropathic pain. In CF’s laboratory, he successfully established mechanical task fMRI in mice that now enables the investigation of brain network processing of mechanical pain in longitudinal studies. In the laboratory of EPZ he investigates behavioral changes related to acute and chronic pain using multimodal assessments. For data analysis he integrates deep- and machine-learning approaches to analyze complex data sets. During his time at the University of Münster, he raised peer-reviewed funding for a project investigating sex differences in plasticity of brain networks during acute and chronic pain. (https://orcid.org/my-orcid?orcid=0000-0001-9792-6042).
My laboratory is interested in the molecular mechanisms that lead to the establishment of chronic pain states. We focus on sensitization of peripheral nociceptors and dorsal horn neurons as a means to better understand how pain becomes chronic. My laboratory has established lines of investigation on mediators and mechanisms of acute and chronic pain and I have been active in the area of pain neuroscience research for 20 years. As a postdoctoral fellow in the lab of Dr. Fernando Cervero at McGill University my research focused on mechanisms of central sensitization and translation regulation in chronic pain conditions. Our work was among the first to demonstrate an important role for translation control in the development of chronic pain states. At University of Arizona and now as a Professor at The University of Texas at Dallas my laboratory has established behavioral pharmacology models, biochemical and imaging testing techniques, in vitro electrophysiology and molecular genetic methods required for the fulfillment of testing novel hypotheses in the pain area. Work from my lab has been important in establishing the role of localized translation in pain amplification. To this end, we have worked extensively with pathways that regulate localized, activity- dependent translation in dorsal root ganglion neurons and made discoveries that give insight into how this promotes increased excitability in nociceptors. We also have extensive experience in the study of neuropathic pain and central mechanisms that drive chronic pain. Our laboratory is highly productive with ~ 180 papers published in ~ 20 years in the pain field.
Conflict of interest
A major focus of work in my lab is the study of human nociceptors. To this end we have created collaborations with organ procurement organizations and surgeons to recover tissues. We have also developed assay to measure the excitability of these cells in vitro, since nociceptor excitability changes are directly linked to neuropathic pain in patients.
Andrew S.C. Rice MB BS, MD, FRCP, FRCA, FFPMRCA, FFPMCAI is Professor of Pain Research at Imperial College London and Honorary Consultant in Pain Medicine at Chelsea and Westminster Hospital, London, United Kingdom. He received his medical degree from St. Mary’s Hospital Medical School in 1982 and his research doctorate from St. Thomas’ Hospital Medical School in 1991. He underwent specialist training in Oxford and at St Thomas’ Hospital and joined the academic staff of Imperial College in 1995.
His translational research programme seeks to elucidate neuropathic pain and enjoys the benefit of a highly interdisciplinary group of researchers and collaborators. Andrew’s research focuses covers both laboratory and clinical research spanning animal models, through deep profiling of patients with a view to personalized medicine, to clinical trials and evidence synthesis by meta-analysis. His focus is on neuropathic pain in the context of infectious diseases (HIV, Herpes Zoster, HTLV-1 and leprosy), diabetic neuropathy and peripheral nerve and cold induced trauma, especially in a military context. He has been a pioneer in the use of deep clinical phenotyping studies to elucidate stratification approaches to empower the concept of precision medicine for the clinical management of neuropathic pain. He is a vocal advocate for tackling the record of translation failure in his field by improving the internal and external validity of pre-clinical research and for innovating evidence synthesis methods in pre-clinical research. He collaborates with historians to “learn the lessons of history” particularly with regards to post amputation pain in First World War veterans and nutritional neuropathies in survivors of captivity in the Far East 1942-45. He has published nearly 250 peer reviewed papers.
Conflict of interest
Andrew SC Rice interests:
• Employee Imperial College London
• Hon Consultant Chelsea and Westminster Hospital NHS Foundation Trust (retired from direct clinical practice)
• Consultancy and advisory board work for Imperial College Consultants- in the last 36 months this has included remunerated work for: AsahiKasei Pharma, Lateral, Pharmnovo, Novartis, Mundipharma, Toray, Confo, Combigene, Orion, Shanghai SIMR Biotech, Vertex, & Science Practice (Wellcome Trust) .
• ASCR is named as an inventor on patents:
• Rice A.S.C., Vandevoorde S. and Lambert D.M Methods using N-(2-propenyl)hexadecanamide and related amides to relieve pain. WO 2005/079771
• Okuse K. et al Methods of treating pain by inhibition of vgf activity EP13702262.0/ WO2013 110945
• Committees:
o International Association for Study of Pain- multiple activities related to President -elect position, and Federation liaison roles (SE and S Asia)
o Member Joint Committee on Vaccine and Immunisation- varicella sub-committee
o Analgesic Clinical Trial Translation: Innovations, Opportunities, and Networks (ACTTION) steering committee member
o Medicines and Healthcare products Regulatory Agency (MHRA), Commission on Human Medicines - Neurology, Pain & Psychiatry Expert Advisory Group
o Grants and studentships - UKRI (Medical Research Council & BBSRC), Versus Arthritis, Alan and Sheila Diamond Trust, Royal British Legion, European Commission, Ministry of Defence, Dr Jennie Gwynn Bequests, The British Pain Society, Royal Society of Medicine
o Royal College of Anaesthetists - Heritage and Archives Committee (2020 - date)
• Lecture honoraria
o MD Cancer Cancer Center -2021
o University California San Francisco. CSF12th Pediatric Pain Master Class (USA) Dec 2021
o Bioevents – Controversies in Neuropathic pain – 2021
o Royal Marsden Hospital 2019
o Indonesian Neurological Association Pain Study Group International Lecture Series Donated to (Association of Southeast Asian Pain Societies (ASEAPS) –Oct 2022
o Malaysian Society of Anaesthesiologists – July 2022
o Siriraj Hospital Bangkok international relations programme- visiting Professorship Nov 2022 – used for expenses
o Pain Association of Singapore- lecture honorarium March 2023
• Author royalties:
o Amazon KDP- Dardanelles to Dunkirk – donated to Halo Trust
o Royal Pharmaceutical Society- British National Formulary- finished 2023
Manuela Schmidt studied Biology at the University of Würzburg. In 2006, she obtained her PhD at the International Max Planck Research School Neurosciences in Göttingen under the supervision of Prof. Dr. Stephan Sigrist. From 2007 to 2012 she worked as a postdoc at The Scripps Research Institute in La Jolla (California) in the laboratory of Prof. Ardem Patapoutian, where she investigated TRP channels and contributed to the discovery and characterization of Piezo2 channels in the context of somatosensation. From 2012 to 2018 she lead her own research group (funded by the Emmy Noether Programme, DFG) at the Max Planck Institute for Experimental Medicine in Göttingen and got appointed as W2-professor at the Faculty of Biology and Psychology of the University of Göttingen in 2019. In 2020, she became full professor at the University of Vienna heading the Division of Pharmacology and Toxicology and became Deputy Head of the Department for Pharmaceutical Sciences. Since September 2022, she has been appointed Vice Dean of the Faculty of Life Sciences.
Daniel Segelcke graduated at the Ruhr University of Bochum, where he received extensive training in behavioral biology and animal pain models for migraine. Following his PhD in 2012, he joined the laboratories of Esther Pogatzki-Zahn (EPZ) at the University of Münster to investigate behavioral, cerebral processing and proteome signatures in animal models for post-surgical, pathogene pain, neuropathic pain, and bone-tumour induced pain. He successfully established novel rodent behavior assays, devices and analytic methods to investigate multidimensional pain modalities in rats and mice in longitudinal studies. Machine learning approaches perform some of these analysis methods. During his time at the University of Münster, he raised peer-reviewed funding for a preclinical systematic review investigating the impact of buprenorphine (opioid) in biomedical animal research.
ORCID: 0000-0002-4405-2596
Google Scholar: H-index: 11, 592 citations
Scopus: H-index: 10, 351 citations